| Year |
Citation |
Score |
| 2024 |
McManus DT, Valanparambil RM, Medina CB, Hu Y, Scharer CD, Sobierajska E, Chang DY, Wieland A, Lee J, Nasti TH, Hashimoto M, Ross JL, Prokhnevska N, Cardenas MA, Gill AL, et al. Early generation of a precursor CD8 T cell that can adapt to acute or chronic viral infection. Research Square. PMID 38410458 DOI: 10.21203/rs.3.rs-3922168/v1 |
0.381 |
|
| 2023 |
Ross JL, Hambardzumyan D. Et tu neutrophils? The brain reprograms neutrophils to facilitate tumor progression. Immunity. 56: 2469-2471. PMID 37967529 DOI: 10.1016/j.immuni.2023.10.006 |
0.603 |
|
| 2023 |
Chen Z, Giotti B, Kaluzova M, Puigdelloses Vallcorba M, Rawat K, Price G, Herting CJ, Piñero G, Cristea S, Ross JL, Ackley J, Maximov V, Szulzewsky F, Thomason W, Marquez-Ropero M, et al. A paracrine circuit of IL-1β/IL-1R1 between myeloid and tumor cells drives genotype-dependent glioblastoma progression. The Journal of Clinical Investigation. PMID 37733448 DOI: 10.1172/JCI163802 |
0.596 |
|
| 2023 |
McSwain LF, Pillsbury CE, Haji-Seyed-Javadi R, Rath SK, Chen V, Huang T, Shahab SW, Kunhiraman H, Ross J, Price GA, Dey A, Hambardzumyan D, MacDonald T, Yu DS, Porter CC, et al. Author Correction: YB1 modulates the DNA damage response in medulloblastoma. Scientific Reports. 13: 9717. PMID 37322047 DOI: 10.1038/s41598-023-36594-3 |
0.483 |
|
| 2023 |
McSwain LF, Pillsbury CE, Haji-Seyed-Javadi R, Rath SK, Chen V, Huang T, Shahab SW, Kunhiraman H, Ross J, Price GA, Dey A, Hambardzumyan D, MacDonald T, Yu DS, Porter CC, et al. YB1 modulates the DNA damage response in medulloblastoma. Scientific Reports. 13: 8087. PMID 37208357 DOI: 10.1038/s41598-023-35220-6 |
0.567 |
|
| 2023 |
Chen Z, Soni N, Pinero G, Giotti B, Eddins DJ, Lindblad KE, Ross JL, Puigdelloses Vallcorba M, Joshi T, Angione A, Thomason W, Keane A, Tsankova NM, Gutmann DH, Lira SA, et al. Monocyte depletion enhances neutrophil influx and proneural to mesenchymal transition in glioblastoma. Nature Communications. 14: 1839. PMID 37012245 DOI: 10.1038/s41467-023-37361-8 |
0.64 |
|
| 2022 |
Lee H, Guo Y, Ross JL, Schoen S, Degertekin FL, Arvanitis C. Spatially targeted brain cancer immunotherapy with closed-loop controlled focused ultrasound and immune checkpoint blockade. Science Advances. 8: eadd2288. PMID 36399574 DOI: 10.1126/sciadv.add2288 |
0.357 |
|
| 2022 |
Hashimoto M, Araki K, Cardenas MA, Li P, Jadhav RR, Kissick HT, Hudson WH, McGuire DJ, Obeng RC, Wieland A, Lee J, McManus DT, Ross JL, Im SJ, Lee J, et al. PD-1 combination therapy with IL-2 modifies CD8 T cell exhaustion program. Nature. PMID 36171288 DOI: 10.1038/s41586-022-05257-0 |
0.577 |
|
| 2022 |
Markwell SM, Ross JL, Olson CL, Brat DJ. Necrotic reshaping of the glioma microenvironment drives disease progression. Acta Neuropathologica. PMID 35039931 DOI: 10.1007/s00401-021-02401-4 |
0.417 |
|
| 2021 |
Ross JL, Vega JV, Plant A, MacDonald TJ, Becher OJ, Hambardzumyan D. Tumor immune landscape of paediatric high-grade gliomas. Brain : a Journal of Neurology. PMID 33856022 DOI: 10.1093/brain/awab155 |
0.655 |
|
| 2020 |
Ross JL, Chen Z, Herting CJ, Grabovska Y, Szulzewsky F, Puigdelloses M, Monterroza L, Switchenko J, Wadhwani NR, Cimino PJ, Mackay A, Jones C, Read RD, MacDonald TJ, Schniederjan M, et al. Platelet-derived growth factor beta is a potent inflammatory driver in paediatric high-grade glioma. Brain : a Journal of Neurology. PMID 33300045 DOI: 10.1093/brain/awaa382 |
0.585 |
|
| 2020 |
Chen Z, Herting CJ, Ross JL, Gabanic B, Puigdelloses Vallcorba M, Szulzewsky F, Wojciechowicz ML, Cimino PJ, Ezhilarasan R, Sulman EP, Ying M, Ma'ayan A, Read RD, Hambardzumyan D. Genetic driver mutations introduced in identical cell-of-origin in murine glioblastoma reveal distinct immune landscapes but similar response to checkpoint blockade. Glia. PMID 32639068 DOI: 10.1002/Glia.23883 |
0.641 |
|
| 2019 |
Kaffes I, Szulzewsky F, Chen Z, Herting CJ, Gabanic B, Velázquez Vega JE, Shelton J, Switchenko JM, Ross JL, McSwain LF, Huse JT, Westermark B, Nelander S, Forsberg-Nilsson K, Uhrbom L, et al. Human Mesenchymal glioblastomas are characterized by an increased immune cell presence compared to Proneural and Classical tumors. Oncoimmunology. 8: e1655360. PMID 31646100 DOI: 10.1080/2162402X.2019.1655360 |
0.69 |
|
| 2019 |
Chen Z, Ross JL, Hambardzumyan D. Intravital 2-photon imaging reveals distinct morphology and infiltrative properties of glioblastoma-associated macrophages. Proceedings of the National Academy of Sciences of the United States of America. PMID 31235603 DOI: 10.1073/Pnas.1902366116 |
0.66 |
|
| 2019 |
Núñez FJ, Mendez FM, Kadiyala P, Alghamri MS, Savelieff MG, Garcia-Fabiani MB, Haase S, Koschmann C, Calinescu AA, Kamran N, Saxena M, Patel R, Carney S, Guo MZ, Edwards M, ... ... Ross JL, et al. IDH1-R132H acts as a tumor suppressor in glioma via epigenetic up-regulation of the DNA damage response. Science Translational Medicine. 11. PMID 30760578 DOI: 10.1126/Scitranslmed.Aaq1427 |
0.62 |
|
| 2019 |
Sharma NV, Chau M, Mukherjee S, Ross J, Miller B, Zhang C, Kong J, Tucker-Burden C, Kaissi E, Reitnauer JW, Dundar B, Olson CL, Bix G, Brat DJ. Abstract 1153: Hypoxic microenvironments promote stemness and enhance the directed migration of glioma stem cells Cancer Research. 79: 1153-1153. DOI: 10.1158/1538-7445.Am2019-1153 |
0.423 |
|
| 2019 |
Ross J, Chen Z, Herting C, Szulzewsky F, Becher O, MacDonald T, Schniederjan M, Hambardzumyan D. PDTM-11. GAINING INSIGHTS INTO THE INFLAMMATORY MICROENVIRONMENT OF PEDIATRIC HIGH-GRADE GLIOMAS USING GEMMs AND PATIENT SAMPLES Neuro-Oncology. 21: vi189-vi189. DOI: 10.1093/Neuonc/Noz175.787 |
0.69 |
|
| 2019 |
Markwell S, Ross J, Olson C, Nunez-Santana F, Arvanitis C, Mukherjee S, Brat D. TMOD-37. INTRAVITAL MONITORING DYNAMIC TUMOR MICRO-ENVIRONMENTAL EVOLUTION FOLLOWING HYPOXIA-INDUCED NECROSIS IN GLIOBLASTOMA Neuro-Oncology. 21: vi271-vi271. DOI: 10.1093/Neuonc/Noz175.1136 |
0.503 |
|
| 2019 |
Ross J, Chen Z, Szulzewsky F, Monterroza L, Schniederjan M, Becher O, Hambardzumyan D. TMOD-09. TUMOR ASSOCIATED MACROPHAGE DYNAMICS IN PEDIATRIC HIGH-GRADE GLIOMAS Neuro-Oncology. 21: ii123-ii123. DOI: 10.1093/Neuonc/Noz036.247 |
0.646 |
|
| 2018 |
Ross J, Chen Z, Szulzewsky F, Schniederjan M, Becher O, Hambardzumyan D. PDTM-43. THE ROLE OF TUMOR ASSOCIATED MACROPHAGES IN PEDIATRIC HIGH-GRADE GLIOMA Neuro-Oncology. 20: vi213-vi213. DOI: 10.1093/Neuonc/Noy148.882 |
0.656 |
|
| 2017 |
Ross JL, Cooper LAD, Kong J, Gutman D, Williams M, Tucker-Burden C, McCrary MR, Bouras A, Kaluzova M, Dunn WD, Duong D, Hadjipanayis CG, Brat DJ. 5-Aminolevulinic Acid Guided Sampling of Glioblastoma Microenvironments Identifies Pro-Survival Signaling at Infiltrative Margins. Scientific Reports. 7: 15593. PMID 29142297 DOI: 10.1038/S41598-017-15849-W |
0.448 |
|
| 2017 |
Zhang C, Mukherjee S, Tucker-Burden C, Ross JL, Chau MJ, Kong J, Brat DJ. TRIM8 regulates stemness in glioblastoma through PIAS3-STAT3. Molecular Oncology. PMID 28100038 DOI: 10.1002/1878-0261.12034 |
0.383 |
|
| 2017 |
Ross J, Chau M, Miller B, Mukherjee S, Zhang C, Kong J, Kaissi E, Newsam A, Mahboubi D, Berry J, Tucker-Burden C, Brat D. Tmic-14. Hypoxia Inducible Olig2 Mediates Glioma Stem Cell Migration Neuro-Oncology. 19. DOI: 10.1093/Neuonc/Nox168.1004 |
0.324 |
|
| 2016 |
Ross J, Brat D, Hadjipanayis C, Cooper L, Wiliams M, Bouras A, Kaluzova M, Dunn W, Gutman D, Duong D, McCrary M. TMIC-23. DIFFERENTIAL EXPRESSION OF THERAPEUTIC TARGETS ACROSS TUMOR MICROENVIRONMENTS AND AT INFILTRATIVE MARGINS IN GLIOBLASTOMA Neuro-Oncology. 18: vi204-vi205. DOI: 10.1093/Neuonc/Now212.863 |
0.446 |
|
| Show low-probability matches. |